Thomas Kümler

Medicine & Life Sciences

1. Heart Failure 100%
2. Atrial Fibrillation 84%
3. Registries 81%
4. Venous Thromboembolism 64%
5. Systolic Heart Failure 52%
6. Natriuretic Peptides 48%
7. Outpatients 46%
8. Myocardial Infarction 45%
9. Cardiotoxicity 44%
10. Pulmonary Embolism 41%
11. pro-brain natriuretic peptide (1-76) 41%
12. Atrial Natriuretic Factor 38%
13. Anticoagulants 33%
14. Cardiovascular Diseases 32%
15. Cohort Studies 29%
16. Elderly 26%
17. Randomized Controlled Trials 26%
18. Incidence 26%
19. Mineralocorticoid Receptor Antagonists 26%
20. Breast Neoplasms 25%
21. Galectin 3 25%
22. Testosterone Congeners 25%
23. Left Ventricular Function 25%
24. Atrial Appendage 24%
25. Capecitabine 24%
26. Gangrene 24%
27. Arteriosclerosis 23%
28. Thrombosis 23%
29. Bundle-Branch Block 23%
30. Echocardiography 23%
31. Disseminated Intravascular Coagulation 22%
32. Kidney 22%
33. Heart Valves 21%
34. Oncologists 21%
35. Stroke Volume 21%
36. Infections 20%
37. Duration of Therapy 20%
38. Endocarditis 20%
39. Vasculitis 19%
40. Venous Thrombosis 19%
41. Brain Natriuretic Peptide 19%
42. copeptins 19%
43. Fluorouracil 18%
44. Sarcoma 18%
45. Hypotension 18%
46. Doxorubicin 17%
47. Thorax 17%
48. Thoracic Surgery 17%
49. Ischemia 16%
50. Hospitalization 16%